iZafe Group AB Series B - Asset Resilience Ratio

Latest as of December 2025: 4.69%

iZafe Group AB Series B (IZAFE-B) has an Asset Resilience Ratio of 4.69% as of December 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.

Liquid Assets

Skr1.67 Million

≈ $180.04K USD Cash + Short-term Investments

Total Assets

Skr35.63 Million

≈ $3.83 Million USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio Trend (2016–2025)

This chart shows how iZafe Group AB Series B's Asset Resilience Ratio has changed over time. Check IZAFE-B strategic assets to equity ratio to assess the company's strategic physical and investment asset allocation.

Liquid Assets Composition Over Time

This chart breaks down iZafe Group AB Series B's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see iZafe Group AB Series B market capitalisation.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	Skr1.67 Million	4.69%
Short-term Investments	Skr0.00	0%
Total Liquid Assets	Skr1.67 Million	4.69%

Asset Resilience Insights

Limited Liquidity: iZafe Group AB Series B maintains only 4.69% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company primarily holds liquidity in cash and equivalents rather than short-term investments.

iZafe Group AB Series B Industry Peers by Asset Resilience Ratio

Compare iZafe Group AB Series B's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Hangzhou Alltest Biotech Co. Ltd. A SHG:688606	Medical Instruments & Supplies	11.88%
Daxor Corporation NASDAQ:DXR	Medical Instruments & Supplies	65.10%
Ansell Ltd AU:ANN	Medical Instruments & Supplies	7.53%
Nanosonics Ltd AU:NAN	Medical Instruments & Supplies	46.84%
SDI Ltd AU:SDI	Medical Instruments & Supplies	3.36%
Austco Healthcare Ltd AU:AHC	Medical Instruments & Supplies	15.90%
Trajan Group Holdings Ltd AU:TRJ	Medical Instruments & Supplies	0.29%
Osteopore Ltd AU:OSX	Medical Instruments & Supplies	22.60%

Annual Asset Resilience Ratio for iZafe Group AB Series B (2016–2025)

The table below shows the annual Asset Resilience Ratio data for iZafe Group AB Series B.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2025-12-31	4.69%	Skr1.67 Million ≈ $180.04K	Skr35.63 Million ≈ $3.83 Million	-4.18pp
2024-12-31	8.87%	Skr2.15 Million ≈ $231.37K	Skr24.23 Million ≈ $2.61 Million	-7.98pp
2023-12-31	16.85%	Skr5.83 Million ≈ $627.83K	Skr34.61 Million ≈ $3.73 Million	+13.50pp
2022-12-31	3.35%	Skr1.70 Million ≈ $183.05K	Skr50.70 Million ≈ $5.46 Million	-35.31pp
2021-12-31	38.67%	Skr18.73 Million ≈ $2.02 Million	Skr48.43 Million ≈ $5.21 Million	+31.40pp
2020-12-31	7.26%	Skr2.55 Million ≈ $274.21K	Skr35.08 Million ≈ $3.78 Million	-3.14pp
2019-12-31	10.41%	Skr7.47 Million ≈ $803.57K	Skr71.75 Million ≈ $7.72 Million	+7.64pp
2018-12-31	2.77%	Skr1.21 Million ≈ $129.89K	Skr43.58 Million ≈ $4.69 Million	-23.36pp
2017-12-31	26.13%	Skr3.58 Million ≈ $385.70K	Skr13.71 Million ≈ $1.48 Million	-17.89pp
2016-12-31	44.03%	Skr3.56 Million ≈ $383.44K	Skr8.09 Million ≈ $870.88K	--

pp = percentage points

About iZafe Group AB Series B

ST:IZAFE-B Sweden Medical Instruments & Supplies

Market Cap

$15.51 Million

Skr144.13 Million SEK

Market Cap Rank

#25860 Global

#535 in Sweden

Share Price

Skr0.36

Change (1 day)

+5.34%

52-Week Range

Skr0.30 - Skr0.72

All Time High

Skr16.60